e-Article
A stroma-related gene signature predicts resistance to epirubicin-containing neoadjuvant chemotherapy in breast cancer
Document Type
ConferencePaper
Author
Source
BREAST CANCER RESEARCH AND TREATMENT. 106:S11-S11
Subject
Language
English
English
English
ISSN
0167-6806